JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M414437200 on April 20, 2005

J. Biol. Chem., Vol. 280, Issue 26, 24957-24967, July 1, 2005
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/26/24957    most recent
M414437200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Philipova, R.
Right arrow Articles by Whitaker, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Philipova, R.
Right arrow Articles by Whitaker, M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Inhibiting MAP Kinase Activity Prevents Calcium Transients and Mitosis Entry in Early Sea Urchin Embryos*

Rada Philipova, Mark G. Larman, Calum P. Leckie, Patrick K. Harrison, Laurence Groigno, and Michael Whitaker{ddagger}

From the Institute of Cell and Molecular Biosciences, Faculty of Medical Sciences, University of Newcastle upon Tyne, NE2 4HH, United Kingdom

Received for publication, December 22, 2004 , and in revised form, April 19, 2005.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
A transient calcium increase triggers nuclear envelope breakdown (mitosis entry) in sea urchin embryos. Cdk1/cyclin B kinase activation is also known to be required for mitosis entry. More recently, MAP kinase activity has also been shown to increase during mitosis. In sea urchin embryos, both kinases show a similar activation profile, peaking at the time of mitosis entry. We tested whether the activity of both kinases is required for mitosis entry and whether either kinase controls mitotic calcium signals. We found that reducing the activity of either mitotic kinase prevents nuclear envelope breakdown, despite the presence of a calcium transient, when cdk1/cyclin B kinase activity is alone inhibited. When MAP kinase activity alone was inhibited, the calcium signal was absent, suggesting that MAP kinase activity is required to generate the calcium transient that triggers nuclear envelope breakdown. However, increasing intracellular free calcium by microinjection of calcium buffers or InsP3 while MAP kinase was inhibited did not itself induce nuclear envelope breakdown, indicating that additional MAP kinase-regulated events are necessary. After MAP kinase inhibition early in the cell cycle, the early events of the cell cycle (pronuclear migration/fusion and DNA synthesis) were unaffected, but chromosome condensation and spindle assembly are prevented. These data indicate that in sea urchin embryos, MAP kinase activity is part of a signaling complex alongside two components previously shown to be essential for entry into mitosis: the calcium transient and the increase in cdk1/cyclinB kinase activity.


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
The rapid cycling from interphase to mitosis in early embryos follows the activity of the highly conserved maturation-promoting factor (1). Maturation-promoting factor consists of a regulatory subunit, cyclin B, and a catalytic subunit, cdk1 (2–4). Activation of cdk1 is dependent on it binding to its regulatory subunit, cyclin B, and subsequent phosphorylation events. Levels of cyclin B begin to rise during G2. Once the cdk1/cyclin B kinase complex is formed, it is maintained in an inactive state through phosphorylation of cdk1 at Thr14 and Tyr15 by protein kinases Wee1/Mik1 and Myt1 (5). Activation is a consequence of Thr161 being phosphorylated by the Cdk activating kinase (6, 7) and dephosphorylation of Thr14 and Tyr15 by Cdc25C (8–11).

During interphase, the complex maintains an overall cytoplasmic localization, but during late prophase, as the cell approaches mitosis, active cdk1/cyclin B kinase accumulates in the nucleus (12). Nuclear envelope breakdown (NEB)1 is thought to entail depolymerization of lamins, which are integral proteins of the nuclear membrane (13). Since cdk1 has been shown to phosphorylate nuclear lamins in vitro (14, 15), one possibility is that NEB occurs as the result of lamin phosphorylation by cdk1/cyclin B kinase when it translocates to the nucleus (16). In addition, in sea urchin embryos, it has been shown that a second mitotic kinase, MAP kinase, displays a similar activation profile and localization to that of cdk1/cyclin B kinase, prior to NEB (17, 18). MAP kinase has also been shown to be active during mitosis in somatic cells in culture and in Xenopus cell-free cycling extracts (19, 20). MAP kinase and cdk1/cyclin B kinase can interact to activate mutually and rapidly (21, 22). The activity increase and relocalization of MAP kinase to the nucleus just prior to NEB suggest a possible role in mitosis entry (18).

In sea urchin embryos, a cell messenger signaling event is involved in mitosis entry. Increases in [Ca2+]i have been observed just before and during mitosis in oocytes, embryos, and mammalian somatic cells (23–26). We have shown that these transients are signals that control entry into mitosis (27) and chromatid disjunction (28) in the early cell cycles of sea urchin embryos. The mitotic Ca2+ signals are generated by activation of phospholipase C{gamma}, which leads to inositol 1,4,5-trisphosphate (InsP3)-induced Ca2+ release from internal stores (29, 30). The physiological significance of the mitotic Ca2+ transients in other oocytes and embryos and in mammalian somatic cells is less clear than it is in the sea urchin embryo (31–33), However, there is no doubt that Ca2+ transients and Ca2+ oscillations are frequently detected as the cell approaches and passes through mitosis (34–36). Moreover, stimulation of the activating mitotic phosphatase Cdc25C is dependent on a calmodulin-regulated kinase, calmodulin kinase II (37). Calmodulin kinase II activation is essential for NEB in the sea urchin embryo (38).

It has been shown that chromosome condensation and NEB can be caused prematurely in sea urchin embryos by injecting InsP3 and Ca2+-EGTA buffers (39). However, preventing protein (cyclin) synthesis abolishes cell cycle-associated Ca2+ changes and renders the nucleus insensitive to these exogenously generated Ca2+ increases (39), confirming that cdk1/cyclinB activation is downstream of the calcium signal. It is not known how the cell cycle kinase/phosphatase cascades cause the essential increase in [Ca2+]i just before mitosis.




View larger version (88K):
[in this window]
[in a new window]
  		FIG. 1.
Blocking MAP kinase activity with XCL100 or U0126 prevents NEB. a, recombinant XCL100 (pipette concentration: 20–25 mg/ml) or control vehicle buffer (0.5x phosphate-buffered saline) were microinjected into sea urchin embryos 12–20 min after fertilization. Experiments were terminated after 180 min. Cell volume injections of 0.4, 0.5, and 0.6% give final concentrations of ~1.8, 2.3, and 2.8 µM, respectively. *, statisticallysignificant at 5%, Student's t test between control and XCL100-injected embryos. 5–15 embryos were injected for each treatment. b, blocking cdk1/cyclin B kinase activity with 20 µM roscovitine prevents NEB. Roscovitine was added to sea urchin embryos 35 min after fertilization (57). Embryos were scored for NEB using DIC optics. 100 embryos were counted for each time point. Note that 10 µM roscovitine substantially delays but does not block NEB. c, control and U0126-treated embryos. Varying concentrations of U0126 were added to sea urchin embryos 12 min after fertilization; a comparison of the effect of 100 µM U0126 and its inactive analogue (U0124) showed U0124 to have no effect on NEB. 100 embryos were counted for each point. Embryos were scored for NEB using DIC optics. d, images of control and treated embryos with DIC optics at 70 and 220 min after fertilization. Blocking MAP kinase activity with U0126 or cdk1/cyclin B activity with roscovitine prevented NEB. Scale is indicated by the image, which is 100 µm across.

 
It has been suggested from first principles that incipient activation of cdk1 may modulate Ca2+ release mechanisms to trigger a Ca2+ signal that coordinates and amplifies cdk1 activation (40). This model is consistent with the observation that Cdc25C is in turn activated by the Ca2+-calmodulin-calmodulin kinase II pathway (37). More recent data show that MAP kinase is also active during mitosis (17–20). It too may be required for mitosis entry and may modulate Ca2+ release. We determined whether cdk1/cyclin B kinase activity, MAP kinase activity, or both are required for mitosis entry and capable of modulating the Ca2+ transient associated with NEB in early sea urchin embryos.

We found that inhibiting either mitotic kinase prevents NEB. Preventing increases in MAP kinase activity alone abolished the Ca2+ increase that precedes NEB, indicating that it modulates the Ca2+ release mechanism. The role of MAP kinase during first mitosis in sea urchin embryos extends beyond controlling Ca2+ release since injection of InsP3 or Ca2+-EGTA buffer after inhibition of MAP kinase did not rescue the NEB block. Monitoring chromatin and microtubules in embryos treated with MAP kinase inhibitors revealed that MAP kinase activity is also required for chromosome condensation and bipolar spindle assembly.


   EXPERIMENTAL PROCEDURES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
RESULTS
 DISCUSSION
 REFERENCES
 
Chemicals and Treatments—Unless otherwise stated, all chemicals and materials were obtained from Sigma. Chemicals used in the treatment of embryos were dissolved in Me2SO so that the final chamber concentration of Me2SO (<1%) did not affect the cell cycle (data not shown). U0126 (100 µM; Promega, Southampton, UK) and roscovitine (20 µM) were added to embryos at 12 and 35 min after fertilization, respectively. Roscovitine was a kind gift from Dr L. Meijer.

Gamete Handling and Fertilization—Eggs from the sea urchin Lytechinus pictus (Marinus, CA) were obtained by intracoelomic injection of 0.5 M KCl and collected in artificial sea water (435 mM NaCl, 40 mM MgCl2, 15 mM MgSO4, 11 mM CaCl2, 10 mM KCl, 25 mM NaHCO3, 1 mM EDTA, pH 8.0, osmolarity 950–1000 mosmol). All chemicals were of analytical grade and came from BDH (Poole, UK). Sperm was collected "dry" and stored at 4 °C for no more than 2 days. Eggs were dejellied by passage through a Nitex mesh and attached to glass coverslips with polylysine, as described previously (42). For experiments on fertilized eggs, dejellied eggs were fertilized, stripped of their fertilization envelopes (by Nitex mesh), and then attached to coverslips (as above). Nuclear envelope breakdown was scored using DIC microscopy. Time to NEB in controls was normalized to 70 min in all experiments in which intracellular Ca2+ concentration was monitored.

Expression and Purification of His-tagged XCL100 Fusion Protein and p13suc1 Protein—Plasmid DNA encoding XCL100 was obtained from Dr. X. Wang (43). The fragment was excised from the original construct and subcloned into pBAD/gIII (Invitrogen) before being used to transform LMG194 bacterial cells for expression of the His-tagged fusion protein. An overnight culture of bacteria was diluted 1:10 and grown to an A600 of 0.5 before being induced with a final concentration of 0.2% arabinose for 5 h. After harvest and lysis, purification was carried out on a nickel column (ProBondTM resin, Invitrogen) according to the manufacturer's protocol. The majority of the XCL100 was eluted with 100 mM imidazole. Following purification, the imidazole elution buffer was exchanged with phosphate-buffered saline, and the proteins were concentrated using Microcon® 30 microconcentrators (Millipore, Bedford, MA) to 20–25 mg/ml. Protein concentrations were determined using the BCA reagent assay (Pierce). The construct was injected to a volume of 0.5–0.8% egg volume with a pipette concentration of 20–25 mg/ml, resulting in a cytoplasmic concentration of ≥100 µg/ml.

The Schizosaccharomyces pombe p13suc1 expression vector pET21b.p13suc1 was a kind gift of Dr T. Hunt (ICRF Clare Hall Laboratories, South Mimms, UK). After purification by gel filtration, the protein was coupled to CNBr-Sepharose (Amersham Biosciences) according to the manufacturer's protocol. The final beads contained about 8 mg p13/ml gel.

Microinjection Experiments—All compounds injected were made up in microinjection buffer (0.5 M KCl, 20 mM PIPES, and 1 mM EGTA, pH 6.8). Cytoplasmic concentrations were determined by evaluating cytoplasmic displacement (27) (0.1–1.0% pipette concentration).

The microinjection procedure was performed using drawn borosilicate glass micropipettes (Clark Electromedical Instruments, GCF150F-10), which were manipulated with a hydraulic micromanipulator and a piezoelectric advance (Märzhäuser Wetzlar, Wetzlar-Steindorf, Germany). Solutions were then injected using gas pressure, and the micropipette was withdrawn. The borosilicate glass capillaries with inner filament were pulled by a standard vertical puller (BioScience, Sheerness, Kent, UK) and backfilled using a Hamilton syringe.

Ratiometric Measurement of [Ca2+]i—Fura dextran pentapotassium salt (Fura, Mr 10,000; Molecular Probes, Oregon) was used to avoid internalization of the dye into intracellular compartments. The dye was introduced into the egg by microinjection (final concentration {approx} 10 µM). Two interference band pass filters (350 and 380 nm, bandwidth of 10.3 and 11.3 nm, respectively; Ealing Optics, Watford, UK) were used to illuminate the eggs with light emitted from a 75-watt Xenon short arc lamp (Cairn Research, Faversham, UK). Controlling the 350- and 380-nm filters was a filter wheel (Cairn Research) set to sample every 4 s by acquisition software (UMANS) provided by Dr. C. Regan of Bio-Rad. Fluorescence emission was collected from a 400-nm dichroic mirror and filtered through a 510-nm long pass filter and detected on a PMT (Thorn EMI, Middlesex, UK). The [Ca2+]i concentration was determined using ratiometric analysis (44). Confocal images were acquired using the Leica TCS4D system, as described previously (27). Briefly, a mix of calcium green and tetramethyl rhodamine dextrans (Mr 10,000; Molecular Probes) were microinjected to a final concentration of 10 µM. Images were acquired every 15 s using a 16-scan line average. Topographical representations were generated using IDL software (Research Systems) on an Indigo2 work station (Silicon Graphics). All experiments were undertaken at 17 °C.

In Vitro Protein Kinase Assays, Western Blotting, and Immunoprecipitations—Preparation of sea urchin cell lysates, MAP kinase and hH1 kinase assays, Western blotting, and immunoprecipitation to determine kinase activity in embryos at various times after fertilization were carried out as described previously (18). Immunoprecipitation of active MAP kinase was carried out by using an anti-active MAPK antibody (Promega). The immune complexes were not boiled. Instead, they were left for 15 min at room temperature in sample buffer and then frozen or loaded on gel for electrophoresis and blotting. The blotted complexes were probed with another, monoclonal anti-dual phosphorylated MAPK antibody (New England Biolabs).

Cdk1 activity was measured also after isolation of cdk1/cyclin B kinase from sea urchin extracts using p13suc1-Sepharose binding (45). The isolated cdk1/cyclin B complexes were used in hH1 kinase assays.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
DISCUSSION
 REFERENCES
 
Manipulation of MAP Kinase and cdk1/Cyclin B Kinase Activities and Their Effect on NEB—It was initially thought that there was no increase in MAP kinase activity during mitosis (46–49). More recently, an ERK1-like MAP kinase activity has been detected during mitotic divisions in sea urchin embryos (17, 18), mammalian cell lines (20), and cycling Xenopus extracts (19). The MAP kinase activity peak correlates closely with the timing of NEB (mitosis entry) in sea urchin embryos (18). We blocked MAP kinase activation by microinjecting a specific recombinant inhibitor (MAP kinase phosphatase: XCL100). We also used a small molecule-based approach (MEK inhibitor: U0126). The usefulness of such soluble, fastacting, small molecule inhibitors to examine dynamic cellular pathways has been demonstrated recently in dissecting the spatial and temporal control of cytokinesis (80). We have recently used XCL100 and U0126 to show that the rapid, transient increase in MAP kinase activity at fertilization controls the onset of DNA synthesis (50). We found that inhibiting MAP kinase activation later in the cell cycle with either treatment prevented NEB.

The MAP kinase activity identified in intact sea urchin embryos contains a peptide sequence with 92% identity to ERK1 (18). We used a recombinant MAP kinase-specific phosphatase, Xenopus MAP kinase phosphatase-1 (XCL100), to prevent MAP kinase activation. XCL100 inactivates MAP kinases by dephosphorylating the phosphotyrosine and phosphothreonine regulatory sites and is highly specific for ERK1 and ERK2 (43, 51–53). After the first sharp peak that follows fertilization, the activity of ERK1 quickly subsides. At 10–15 min after fertilization, it reaches its lowest level. At about 20–25 min, it slowly increases again to reach its second maximum at NEB (18). XCL100 protein was microinjected 12–20 min after fertilization to block this second, NEB-associated increase in MAP kinase activity, whereas sparing the first. A final intracellular concentration of 1.8 µM delayed NEB significantly; ≥2.8 µM caused a complete block over a 3-h observation period and was used in subsequent experiments (Fig. 1a).

U0126 is a compound that inhibits the upstream activator of ERK, MEK. U0126 acts as a non-competitive inhibitor for the MEK1 and MEK2 ATP binding sites (54, 55). The inhibitor was added at 12 min, again to spare the fertilization-associated MAP kinase increase (we found that addition at later times before mitosis did not produce consistent inhibition). Three different concentrations of U0126 were tested (Fig. 1c). 25 and 50 µM concentrations delayed NEB in all embryos by 20 and 30 min, respectively. A concentration of 100 µM blocked the cell cycle in 75–85% of the embryos and delayed NEB by 1 h in the rest of them (data from 16 experiments). Treatment with 100 µM U0124, the negative control for U0126, at 12 min did not inhibit NEB, and the embryos proceeded through the cell cycle normally. These data with U0126 confirmed the results obtained with the recombinant XCL100 protein and further demonstrated that MEK inhibition also prevents entry into mitosis.

As with MAP kinase, there are two peaks of cdk1/cyclin B kinase activity following fertilization (18). The first is very small and may represent G1 activation of other cdks. The second increase begins around 30–40 min post-fertilization and peaks during mitosis. The requirement for an increase in cdk1/cyclin B kinase activity in sea urchin embryos has already been shown using roscovitine, a specific cdk inhibitor (56, 57) that reduces cdk1/cyclin B kinase activity by blocking the ATP binding pocket of cdk1. Roscovitine was added at 35 min post-fertilization to spare the minor post-fertilization increase but inhibit the second increase in cdk1/cyclin B kinase activity (it was effective when added up to 60 min after fertilization (56 and data not shown). 20 µM was required to maintain a block of NEB for a time period greater than one mitotic cycle in controls, when added at 35 min after fertilization (Fig. 1b). This is similar to a concentration previously reported to block NEB in the sea urchin species Shaerechinus granularis (56).

Fig. 1d shows images of embryos taken with DIC optics at 70 and 220 min after fertilization. At 70 min, NEB has just occurred in control embryos. The mitotic asters can be seen at either end of the disappearing nuclear envelope. By 220 min, the control embryos have undergone two cell divisions, whereas treated embryos are arrested at the one-cell stage with their nuclear envelopes intact. These data showed that activation of both MAP kinase and cdk1/cyclin B kinase is necessary for mitosis to occur.

U0126 and Roscovitine Inhibit the Activity Levels of Their Respective Kinases Independently—We used two independent methods to confirm that treating sea urchin embryos at 12 min post-fertilization inhibited the increase in MAP kinase activity that normally follows pronuclear fusion and peaks at NEB. We monitored MAP kinase activity in embryos using myelin basic protein (MBP) as a substrate (18). Fig. 2ai shows MBP kinase activity in sea urchin embryo lysates, made at successive time points as the control embryos first entered then completed mitosis. U0126 completely abolished the increase in MAP kinase activity. Secondly, by carrying out immunoprecipitations and probing the blotted complexes with a monoclonal anti-dual phosphorylated MAP kinase antibody (see "Experimental Procedures"), we confirmed that U0126 prevents the activation (mobility shift) that is observed during mitosis in control immunoprecipitations (Fig. 2aii). We have determined that the mobility shift is seen when MAP kinase activity is high immediately after fertilization (18, 50) and during mitosis (Fig. 2aii). The shifted band is absent when MAP kinase activity is low in un-fertilized eggs and in eggs treated with U0126 to block the rapid post-fertilization increase in MAP kinase activity (50).

U0126 is known to inhibit cdk1/cyclinB activity in some circumstances. It was thus important to ensure that treating sea urchin embryos with U0126 (at 12 min post-fertilization) does not inhibit cdk1/cyclin B kinase activation. Histone H1 was used as a substrate in embryo extracts (Fig. 2i) and after isolation of cdk1/cyclin B kinase using p13suc1-Sepharose binding (Fig. 2ii). Both methods show that U0126 does not inhibit cdk1/cyclin B kinase activation, although interestingly, the timing of the peak in activity does appear to precede slightly that observed in control embryos (Fig. 2, cii and e; we did not investigate this further). The maximal activity in treated embryos was slightly and significantly lower (86.8 ± 1.1% mean ± S.E. of control activity from three independent experiments).



View larger version (43K):
[in this window]
[in a new window]
  		FIG. 2.
Mitotic kinase assays. a and b, panel i, MAP kinase activities in cell lysates isolated at the time points shown from intact control and treated embryos undergoing the cell cycle were measured with MBP as a substrate. panel ii, to confirm these results, we carried out immunoprecipitations followed by Western blotting using two different anti-dual phosphorylated MAP kinase antibodies (see "Experimental Procedures"). The active MAP kinase was precipitated from the same extracts used in the kinase assays. The time points for immunoprecipitated samples corresponded to the peak of MAP kinase activities obtained in total cell extracts. MAP kinase activation leads to the appearance of a gel-shifted band (50) (arrows). MAP kinase activation and the gel shift were prevented by 100 µM U0126 (a) but not by 20 µM roscovitine (+Rosc)(b). c, simultaneous measurement of MAP kinase (blue lines and symbols), histone H1 kinase (blue lines and symbols), and NEB (red lines and symbols) in embryos treated with U0126. At a concentration of U0126 (100 µM) that completely inhibits NEB, MAP kinase activity was absent, whereas histone H1 kinase activity was slightly diminished and advanced slightly in timing. At a concentration of U0126 that substantially delayed NEB, both MAP kinase activation and histone H1 kinase activation were similarly delayed. d and e, Cdk1/cyclin B kinase activities in cell extracts from control and treated embryos undergoing cell cycle were measured using hH1 as a substrate. Additionally, cdk1/cyclin B kinase was isolated from the same extracts using p13suc1-Sepharose beads and assayed for histone H1 kinase activity. 20 µM roscovitine effectively abolished cdk1/cyclin B kinase activity as measured by both methods, whereas 100 µM U0126 led to a small decrease and an advance in cdk1/cyclin B kinase activation.

 
We also investigated the effects of lower concentrations of U0126 that did not block but delayed NEB (Fig. 2c). MAP kinase and cdk1/cyclin B activities were measured in time point lysates from intact embryos treated with 50 µM U0126 at 12 min after fertilization (Fig. 2, ciii and iv). NEB was delayed by 30 min; control embryos showed 98% NEB at 90 min, and inhibited embryos showed 95% NEB at 120 min. MAP kinase activation was not abolished. It occurred but with a 30-min delay and with a reduced activity. Interestingly, cdk1/cyclin B was activated to the same extent as in controls, but the peak activity was also delayed by 30 min, suggesting that MAP kinase is upstream of cdk1/cyclinB in this signaling pathway.



View larger version (23K):
[in this window]
[in a new window]
  		FIG. 3.
The transient [Ca2+]i increase associated with NEB is inhibited by XCL100 and U0126. Ratiometric [Ca2+]i measurements in control sea urchin embryos and in embryos treated with 2.8 µM XCL100 12–20 min (a), 100 µM U0126 12 min (b), or 20 µM roscovitine 35 min (c) are shown. Controls (blue traces) show two peaks of calcium just before NEB (*) and at anaphase (#). Both these peaks are absent in embryos treated with U0126 or XCL100 (a and b). A peak with the same magnitude and timing as the NEB peak is seen in roscovitine embryos (*), but the anaphase peak (#) is absent. Embryos were injected with Fura2 dextran (10 µM) 25–35 min after fertilization. Representative experiments are shown from experiments on 4–7 eggs in each case. ci and cii, topographical representations of confocal images taken at the base and peak of the Ca2+ increase (* in c) for both control and roscovitine-treated embryos, showing spatial information. The embryo is 100 µm in diameter.

 
These results demonstrated that NEB does not occur if MAP kinase activity is abolished, and there is a strong indication that the timing of cdk1/cyclin B activation at mitosis in sea urchin embryos is MAP kinase-dependent (see "Discussion"). Using the methods described above, we confirmed that roscovitine inhibited cdk1/cyclin B kinase activity in intact embryos (Fig. 2di–ii) and that cdk1/cyclin B kinase activity was affected only slightly by treatment with 100 µM U0126 (Fig. 2ei–ii).

The NEB-associated [Ca2+]i Transient Requires MAP Kinase Activation—We have previously described small (50–100 nM) calcium transients that occur just before NEB and anaphase onset (29) and that are absolutely required for mitosis entry (27) and anaphase onset (28) to occur. We determined whether these transients depend on activation of the mitotic kinases. Embryos were injected with the calcium indicator dye Fura2 dextran between 25–35 min after fertilization (27, 44).

Microinjecting the recombinant MAP kinase inhibitor XCL100 (2.8 µM final concentration at 12–20 min after fertilization) completely suppressed the mitotic Ca2+ transients (Fig. 3a). Treatment of sea urchin embryos with 100 µM U0126 12 min after fertilization also suppressed the mitotic Ca2+ signals in six of seven embryos (Fig. 3b). The one embryo that did show a transient also showed a 37 min delay to NEB, with the Ca2+ increase occurring just before NEB (not shown).

We then tested the effects of inhibiting cdk1/cyclin B kinase activity with 20 µM roscovitine (added at 35 min after fertilization) on the mitotic Ca2+ transients. In five of seven embryos, a Ca2+ signal comparable with those seen in parallel control embryos just before entry into mitosis was observed, whereas the anaphase calcium signal (28, 29) was abolished (Fig. 3c). In five roscovitine-treated embryos, the Ca2+ transient (magnitude: 56.6 ± 11.7 nM; mean and S.E.) occurred 67.1 ± 1.8 min after fertilization, whereas in five control embryos, the transient (magnitude: 43.3 ± 7.5 nM) was seen 70.0 ± 4.5 min after fertilization (Fig. 3c). Neither of these parameters is significantly different at the 20% level between groups. We also confirmed that the Ca2+ transient in roscovitine-treated embryos had the same spatial distribution to that observed in control embryos. A confocal imaging system and a calcium green dextran/rhodamine dextran ratiometric method (28) were used to monitor the Ca2+ transient in embryos treated with roscovitine. Fig. 3ci–ii show a topographical representation of the Ca2+ levels at the base and peak of the Ca2+ rise. In cdk-inhibited embryos (Fig. 3cii), as in control embryos (Fig. 3ci), the Ca2+ increase is global. These data demonstrated that roscovitine does not interfere with the NEB Ca2+ signaling mechanism either through blocking cdk1 or in its own right. We confirmed this by measuring the Ca2+ transients induced by InsP3 microinjection in the presence of 20 µM roscovitine. In six roscovitine-treated embryos, the magnitude and rise times in response to 50 µM InsP3 were comparable with controls (magnitudes: 1.3 ± 0.1 µM, 1.3 ± 0.2 µM; t1/2: 17.3 ± 0.8 s, 17.33 ± 4.0 s, respectively). NEB did not take place after microinjection of InsP3 (Table I), as predicted if cdk1/cyclin B kinase activation is downstream of the calcium signal. These experiments indicated that the mitosis entry Ca2+ signal that occurs just before NEB is dependent on activation of MAP kinase but does not require activation of cdk1/cyclin B kinase.


View this table:
[in this window]
[in a new window]
  		TABLE I
Number of embryos that underwent NEB in response to either InsP3 or Ca2+-EGTA buffer in the presence of various inhibitors of MAP kinase and cdk1 Embryos were either injected with 10 µM InsP3 or 1 µM free Ca2+ (pipette concentration of Ca/EGTA buffer 50–80 mM) after being treated with 100 µM U0126, 60 µM aphidicolin, 20 µM roscovitine, or 150 µM emetine. NEB was scored using DIC optics.

 
Neither InsP3 or Ca2+-EGTA Buffer Injections Rescue Blocks to NEB—Injection of InsP3 or Ca2+-EGTA buffers within 20 min of normal mitosis entry can trigger premature NEB in sea urchin embryos (39), indicating that a Ca2+ increase alone is sufficient to trigger NEB as mitosis approaches. We determined whether InsP3 or Ca2+-EGTA buffer injection triggered NEB when mitosis entry is inhibited. Table I shows that under conditions in which MAP kinase activity is inhibited, neither InsP3 (10 µM final cytosolic concentration) nor Ca2+ buffer injection (Ca2+-EGTA buffer containing 1 µM free calcium as described previously (39)) results in NEB. Increasing calcium did not overcome the inhibition of NEB caused by abrogating cdk1/cyclin B kinase activity with roscovitine (Table I), as expected from its position downstream of calcium in the signaling pathway. This result is consistent with the finding that a normal NEB-related Ca2+ increase was observed in roscovitine-treated embryos (Fig. 3c) and that InsP3-triggered Ca2+ release was unaffected (see above). These data indicated that for mitosis entry to occur, additional cell cycle events besides the calcium increase require activation of MAP kinase.

MAP Kinase Inhibition Affects DNA Condensation but Not Sperm DNA Decondensation or DNA Synthesis—At the time at which MAP kinase activity begins to rise again to its second, mitotic peak (the time at which we added MAP kinase inhibitors), several cell cycle events that precede entry into mitosis had yet to occur. It was instructive to observe which additional cell cycle events were dependent on the pre-mitosis MAP kinase peak.

At fertilization, the sperm enters the egg, and the male nucleus, containing highly condensed DNA, is released into the female cytoplasm. A process of pronuclear migration begins. Microtubules elongate to form the female aster and bring the female nucleus to the center of the egg (58). The male nucleus migrates along the female astral microtubules to reach the egg pronucleus about 20 min after fertilization. At this stage, the two nuclei fuse. The nucleus of the egg contains the homogeneous, decondensed female chromatin (Fig. 4a, Control, 25 min). As soon as the highly packed sperm chromatin merges with the female nucleus, it undergoes rapid decondensation; at 45–50 min after fertilization, the male chromosomes in controls are completely uncoiled, and DNA replication has already begun. DNA staining with Hoechst 33342 dye revealed that decondensation of sperm chromatin was not blocked by either XCL100 or U0126 (Fig. 4a).

Fig. 4b shows that blocking MAP kinase activation with U0126 at 12 min does not interfere with DNA synthesis. Both treated and untreated cells incorporate thymidine to the same extent (Fig. 4b, Control and U0126-treated at 12 min). This experiment showed that DNA replication was initiated and that DNA synthesis occurred when the inhibitor was added as the second increase in MAP kinase activity began and, indeed, before the onset of DNA synthesis itself. These early cell cycle events were thus independent of mid-cycle MAP kinase activation. We have previously determined that they are dependent on the early rapid and transient increase in MAP kinase activity immediately after fertilization (50).

MAP Kinase Inhibition Prevents NEB and Chromatin Condensation and Affects Bipolar Spindle Assembly—We then looked at the events of mitosis. Control embryos underwent NEB at 80 min after fertilization (Fig. 5) followed by condensation of mitotic chromosomes, metaphase at 100 min, and anaphase at 110 min. By 120 min after fertilization, cytokinesis and reformation of the two daughter nuclei were completed. Both the MAP kinase phosphatase and the MEK inhibitor caused an identical cell cycle block. XCL100-microinjected and U0126-treated embryos were arrested with partly and improperly condensed DNA and also with intact nuclear envelopes as long as 170 min after fertilization. By this time, the control cells were already at the four-cell stage (Fig. 5a).

In addition, inhibiting MAP kinase with XCL100 and U0126 appeared under DIC optics to prevent the formation of a bipolar spindle. ERK1 has been previously shown to be localized on the mitotic apparatus in sea urchin embryos (18). To confirm an effect on spindle function, rhodamine-labeled tubulin (50 µg/ml) was microinjected at 25 min post-fertilization in control and in embryos treated with 100 µM U0126. A third group of embryos was microinjected with XCL100 phosphatase (100 µg/ml) mixed with rhodamine-labeled tubulin (Fig. 5b). Control embryos duplicated their centrosomes, which were found at 60 min at both sides of the nucleus (see Control panel). These embryos also formed mitotic spindles at 90 min. Neither XCL100- nor U0126-inhibited embryos were able to form bipolar spindles. Tubulin was found disorganized around the nucleus. MEK/ERK1 activity is therefore also needed for the proper organization of the microtubules and formation of functional spindle before entry into mitosis.


   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
REFERENCES
 
We have reported that ERK1 MAP kinase activity increases during mitosis in sea urchin embryos (18). We showed that blocking MAP kinase activation either directly using the recombinant MAP kinase-specific phosphatase XCL100 or indirectly by inhibiting the upstream activator MEK using U0126 prevents mitosis entry. These maneuvers also abolish the Ca2+ transient that precedes and triggers NEB in the first cell cycle of sea urchin embryos (27). Inhibition of MAP kinase activity also leads to incomplete chromatin condensation and the absence of a bipolar spindle.



View larger version (51K):
[in this window]
[in a new window]
  		FIG. 4.
MAP kinase inhibition does not affect early cell cycle events. a, chromatin stained with the DNA dye H33342 [GenBank] . Sperm chromatin is relatively condensed within the zygote nucleus immediately after fusion of male and female pronuclei. It then gradually disperses within the zygote nucleus. This process is unaffected by treatment with XCL100 or U0126. The embryo is 100 µm in diameter. b, DNA synthesis measured by incorporation of [3H]thymidine into DNA is unaffected by 100 µM U0126 added at 12 min.

 



View larger version (47K):
[in this window]
[in a new window]
  		FIG. 5.
Abrogating MAP kinase activity leads to incomplete chromatin condensation and spindle assembly at the time of mitosis. a, chromatin stained with the DNA dye H 33342. Although control embryos are undergoing mitosis with chromatin condensation and chromosome separation, XCL100- and U0126-treated embryos show only partial chromatin condensation. One cell embryo is 100 µmin diameter. b, microtubule organization at the time of mitosis revealed by microinjection of rhodamine tubulin and confocal microscopy. XCL100- and U0126-treated embryos fail to form a bipolar spindle. One cell embryo is 100 µm in diameter.

 
MAP Kinase Activation and cdk1/CyclinB Activity—A significant finding was that MAP kinase activation and cdk1/cyclinB activation can be separately inhibited in early sea urchin embryos and that both kinases are independently required for mitosis entry. Two inhibitors with quite distinct modes of action on the MAP kinase pathway produce identical inhibitory phenotypes while not affecting activation of cdk1/cyclin B kinase. The cdk inhibitor roscovitine blocks cdk1/cyclinB activation without affecting MAP kinase. Thus, the effects that we report on calcium signaling, NEB, chromatin condensation, and spindle assembly can be ascribed to MAP kinase, not to direct or indirect inhibition of cdk1/cyclinB (56).

We also found, however, at concentrations of MAP kinase inhibitor that delayed rather than blocked NEB, that activation of cdk1/cyclinB was similarly delayed. This observation suggests a complex interaction between MAP kinase and cdk1/cyclinB that we are now investigating. It implies the possibility that cdk1/cyclinB activation is controlled by MAP kinase (59). It is notable that the transition from delay with activation to complete block occurred over a very narrow concentration range of both MAP kinase inhibitors; this and the observation that the MAP kinase activity was sensitive to the MEK inhibitor only at the very onset of mid-cycle MAP kinase activity suggest strong positive feedback during MAP kinase activation (59).

MAP Kinase, Not cdk1/CyclinB, Controls the NEB-associated Calcium Signal—An a priori model of the interaction between cell cycle calcium signals and the cell cycle kinase/phosphatase regulatory network suggested that the NEB calcium signal might be activated by a threshold level of cdk1/cyclinB activity; in this model, the role of the calcium signal was to amplify the rise of cdk1/cyclinB activity by feed-forward onto cdc-25 (40). Our data were consistent with the latter postulate but not the former. Since the NEB calcium signal is blocked by inhibition of the MAP kinase pathway, but not by a cdk inhibitor, it is clear that cdk plays no direct part in generating the signal. The calcium signal is instead under the control of MAP kinase. On the other hand, our observation that microinjection of calcium or InsP3 cannot induce NEB in the presence of a cdk inhibitor confirmed the supposition that cdk1/cyclinB acts downstream of the calcium signal. The small reduction of cdk1/cyclin B kinase activation in the absence of MAP kinase activation is consistent with the idea that calcium contributes to cdk1/cyclin B activation (37, 40).

The link between MAP kinase activation and the Ca2+ signal is not known. One obvious possibility is that MAP kinase directly or indirectly activates phospholipase C{gamma}, the activity of which is known to be required for NEB in sea urchin embryos (30). The phospholipase C{gamma} would in turn produce the transient rise in InsP3 production that is observed at mitosis entry (29).

The requirement for MAP kinase at mitosis entry clearly extends beyond triggering the Ca2+ release mechanism since injection of InsP3 or Ca2+-EGTA buffers was unable to release the NEB block induced by MAP kinase inhibition. We conclude that all three events are required for entry into mitosis: MAP kinase activation, the calcium signal, and cdk1/cyclinB activation.

Condensation of Mitotic Chromosomes and Formation of a Bipolar Spindle Are Blocked if the MEK/ERK Pathway Is Inactive—MAP kinase immunoreactivity is concentrated in the nucleus just before NEB (18). We show here that in the absence of high MAP kinase activity, chromosome clustering in the intact nucleus eventually occurs, but condensed (super-coiled) chromosomes are not formed.

Two key processes during chromatin condensation are the elimination of catenation of the sister DNA strands by topoisomerases and the packaging of the strands into nucleosomes and thus chromatids by histones (Ref. 60, and for reviews, see Refs. 61 and 62). Topoisomerases become highly phosphorylated during G2 and M phases, and histone H3 is phosphorylated during the final stages of chromatin condensation (63), a phosphorylation essential for complete chromatin condensation (64). It has been shown that histone H3 is phosphorylated by the downstream activation of the MAP kinase pathway, p90Rsk (65, 66). It has also been found that topoisomerase II{alpha} is activated by MAP kinase (in this case an ERK2 (67)). These observations indicate that MAP kinase plays an important part in the molecular mechanisms of chromatin condensation.

The bipolarity of the mitotic spindle in sea urchins is fully developed at the time of time of NEB, with spindle poles well separated. We found here that in the absence of active MAP kinase, microtubules become disorganized around the intact nucleus. This is not a simple consequence of inhibition of NEB since embryos treated with the DNA synthesis inhibitor aphidicolin form a functional bipolar spindle although failing to undergo NEB (68, 69). MAP kinase inhibitors have been shown to affect microtubule organization. Potentiation of a Taxol-induced increase in tubulin polymerization has been reported in vitro, along with the production of microtubule bundles in vivo, in response to inhibition of MAP kinase activity (70). Inhibiting activation of MEK in Xenopus extracts through immunodepletion or PD98059 (19) also induces the formation of large asters. Adding active MAP kinase to Xenopus egg extracts during interphase causes microtubule shortening and organization that resembles mitotic arrays (71). Two proteins involved in microtubule depolymerization, tau and stathmin/Op18, are both phosphorylated during mitosis at sites that can be targeted by ERK (72–78).

Dual Roles for MAP Kinase Activation during the First Cell Cycle of Sea Urchin Embryos—We have reported that fertilization results in two peaks of MAP kinase (ERK) activity, one immediately after fertilization and the other at mitosis (18). The first peak of activity has been shown to be responsible for the initiation of DNA synthesis and for decondensation of the sperm chromatin (50), in contrast to earlier reports that suggested that a fall in MAP kinase was involved (41, 79). We show here that the second increase in activity coordinates events necessary for entry into mitosis.

Conclusion—This study showed that MAP kinase plays a key role in triggering mitosis entry in early sea urchin embryos by triggering the appropriate calcium signals and by its promotion of spindle assembly and chromatin condensation. Building on previous work (27), it also showed that the calcium signal, ERK1 activation, and cdk1/cyclin B kinase activation are signals that are independently required for mitosis entry. Our data also suggested that these three signals are interdependent; these interactions bear further investigation.


   FOOTNOTES
 
* This work was supported by the Wellcome Trust. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

{ddagger} To whom correspondence should be addressed. Tel.: 44-191-222-5264; Fax: 44-191-222-5164; E-mail: michael.whitaker{at}ncl.ac.uk.

1 The abbreviations used are: NEB, nuclear envelope breakdown; InsP3, inositol 1,4,5-trisphosphate; XCL100, Xenopus MAP kinase phosphatase-1; MAP, microtubule-activated protein; MAPK, MAP kinase; ERK, extracellular signal-regulated kinase; MEK, MAPK/ERK kinase; DIC, differential interference contrast; MBP, myelin basic protein; PIPES, 1,4-piperazinediethanesulfonic acid. Back


   ACKNOWLEDGMENTS
 
We thank L. Meijer for the kind gift of roscovitine and X. Wang for generously providing the XCL100 construct. We are also grateful to M. Sinclair for assistance with protein purification and to Michael Aitchison for preparing the figures.



   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Murray, A. W., and Kirschner, M. W. (1989) Nature 339, 275-280[CrossRef][Medline] [Order article via Infotrieve]
  2. Dunphy, W. G., Brizuela, L., Beach, D., and Newport, J. (1988) Cell 54, 423-431[CrossRef][Medline] [Order article via Infotrieve]
  3. Labbe, J. C., Capony, J.-P., Caput, D., Cavadore, J.-C., Derancourt, J., Kaghad, M., Lelias, J. M., Picard, A., and Doree, M. (1989) EMBO J. 8, 3053-3058[Medline] [Order article via Infotrieve]
  4. Gautier, J., Minshull, J., Lohka, M., Glotzer, M., Hunt, T., and Maller, J. L. (1990) Cell 60, 487-494[CrossRef][Medline] [Order article via Infotrieve]
  5. Lew, D. J., and Kornbluth, S. (1996) Curr. Opin. Cell Biol. 8, 795-804[CrossRef][Medline] [Order article via Infotrieve]
  6. Docommun, B., Brambilla, P., Felix, M. A., N. R., Jr., F., Karsenti, E., and Draetta, G. (1991) EMBO J. 11, 3311-3319
  7. Solomon, M. J., Lee, T., and Kirschner, M. W. (1992) Mol. Biol. Cell 1, 13-27[Medline] [Order article via Infotrieve]
  8. Dunphy, W. G., and Kumagai, A. (1991) Cell 67, 189-196[CrossRef][Medline] [Order article via Infotrieve]
  9. Gautier, J., Solomon, M. J., Booher, R. N., Bazan, J. F., and Kirschner, M. W. (1991) Cell 67, 197-211[CrossRef][Medline] [Order article via Infotrieve]
  10. Dunphy, W. G. (1994) Trends Cell Biol. 4, 202-207[CrossRef][Medline] [Order article via Infotrieve]
  11. Takizawa, C. G., and Morgan, D. O. (2000) Curr. Opin. Cell Biol. 12, 658-665[CrossRef][Medline] [Order article via Infotrieve]
  12. Hagting, A., Karlsson, C., Clute, P., Jackman, M., and Pines, J. (1998) EMBO J. 17, 4127-4138[CrossRef][Medline] [Order article via Infotrieve]
  13. Newport, J., and Spann, T. (1987) Cell 48, 219-230[CrossRef][Medline] [Order article via Infotrieve]
  14. Peter, M., Nakagawa, J., Doree, M., Labbe, J. C., and Nigg, E. A. (1990) Cell 61, 591-602[CrossRef][Medline] [Order article via Infotrieve]
  15. Peter, M., Heitlinger, E., Haner, M., Aebi, U., and Nigg, E. A. (1991) EMBO J. 10, 1535-1544[Medline] [Order article via Infotrieve]
  16. Nigg, E. A. (1992) Curr. Opin. Cell Biol. 4, 105-109[CrossRef][Medline] [Order article via Infotrieve]
  17. Chiri, S., De Nadai, C., and Ciapa, B. (1998) J. Cell Sci. 111, 2519-2527[Abstract]
  18. Philipova, R., and Whitaker, M. (1998) J. Cell Sci. 111, 2497-2505[Abstract]
  19. Guadagno, T. M., and Ferrell, J. E. (1998) Science 282, 1312-1315[Abstract/Free Full Text]
  20. Shapiro, P. A., Vaisberg, E., Hunt, A. J., Tolwinski, N. S., Whaken, A. M., McIntosh, J. R., and Ahn, N. G. (1998) J. Cell Sci. 142, 1533-1545
  21. Ferrell, J. E., and Machleder, E. M. (1998) Science 280, 895-898[Abstract/Free Full Text]
  22. Yue, J., and Ferrell James, E. (2004) Curr. Biol. - CB 14, 1581-1586
  23. Whitaker, M., and Patel, R. (1990) Development 108, 525-542[Abstract/Free Full Text]
  24. Hepler, P. K. (1994) Cell Calcium 16, 322-330[CrossRef][Medline] [Order article via Infotrieve]
  25. Berridge, M. J. (1995) BioEssays 17, 491-500[CrossRef][Medline] [Order article via Infotrieve]
  26. Santella, L. (1998) Biochem. Biophys. Res. Commun. 244, 317-324[CrossRef][Medline] [Order article via Infotrieve]
  27. Wilding, M., Wright, E. M., Patel, R., Ellis-Davies, G., and Whitaker, M. (1996) J. Cell Biol. 135, 191-199[Abstract/Free Full Text]
  28. Groigno, L., and Whitaker, M. (1998) Cell 92, 193-204[CrossRef][Medline] [Order article via Infotrieve]
  29. Ciapa, B., Pesando, D., Wilding, M., and Whitaker, M. (1994) Nature 368, 875-878[CrossRef][Medline] [Order article via Infotrieve]
  30. Shearer, J., De Nadai, C., Emily-Fenouil, F., Gache, C., Whitaker, M., and Ciapa, B. (1999) Development 126, 2273-2284[Abstract]
  31. Tombes, R. M., and Borisy, G. G. (1989) J. Cell Biol. 109, 627-636[Abstract/Free Full Text]
  32. Tombes, R. M., Simerly, C., Borisy, G. G., and Schatten, G. (1992) J. Cell Biol. 117, 799-811[Abstract/Free Full Text]
  33. Whitaker, M., and Larman, M. (2001) Semin. Cell Dev. Biol. 12, 53-58[CrossRef][Medline] [Order article via Infotrieve]
  34. Steinhardt, R. A., and Alderton, J. (1988) Nature 332, 364-366[CrossRef][Medline] [Order article via Infotrieve]
  35. Kao, J. P. Y., Alderton, J., Tsien, R. Y., and Steinhardt, R. A. (1990) J. Cell Biol. 111, 183-196[Abstract/Free Full Text]
  36. Kono, T., Jones, K. T., Bos-Mikich, A., Whittingham, D. G., and Carroll, J. (1996) J. Cell Biol. 132, 915-923[Abstract/Free Full Text]
  37. Patel, R., Holt, M., Philipova, R., Moss, S., Hidaka, H., and Whitaker, M. (1999) J. Biol. Chem. 274, 7958-7968[Abstract/Free Full Text]
  38. Baitinger, C., Alderton, J., Poenie, M., Schulman, H., and Steinhardt, R. A. (1990) J. Cell Biol. 111, 1763-1773[Abstract/Free Full Text]
  39. Twigg, J., Patel, R., and Whitaker, M. (1988) Nature 332, 366-369[CrossRef][Medline] [Order article via Infotrieve]
  40. Swanson, C. A., Arkin, A. P., and Ross, J. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 1194-1199[Abstract/Free Full Text]
  41. Carroll, D. J., Albay, D. T., Hoang, K. M., O'Neill, F. J., Kumano, M., and Foltz, K. R. (2000) Dev. Biol. 217, 179-191[CrossRef][Medline] [Order article via Infotrieve]
  42. Becchetti, A., and Whitaker, M. (1997) Development 124, 1099-1107[Abstract]
  43. Wang, X. M., Zhai, Y., and Ferrel, J. E., Jr. (1997) J. Cell Biol. 137
  44. Swann, K., and Whitaker, M. (1986) J. Cell Biol. 103, 2333-2342[Abstract/Free Full Text]
  45. Edgecombe, M., Patel, R., and Whitaker, M. (1991) EMBO J. 10, 3769-3775[Medline] [Order article via Infotrieve]
  46. Ferrell, J. E., Wu, M., Gerhaart, J. C., and Martin, G. S. (1991) Mol. Cell. Biol. 11, 1965-1971[Abstract/Free Full Text]
  47. Tamemoto, H., Kadowaki, T., Tobe, K., Ueki, K., Izumi, T., Chatani, Y., Kohno, M., Kasuga, M., Yazaki, Y., and Akanuma, Y. (1992) J. Biol. Chem. 267, 20293-20297[Abstract/Free Full Text]
  48. Verlhac, M. H., Kubiak, J. Z., Clarke, H. J., and Maro, B. (1994) Development 120, 1017-1025[Abstract]
  49. Edelmann, W., Cohen, P. E., Kane, M., Lau, K., Morrow, B., Bennett, S., Umar, A., Kunkel, T., Cattoretti, G., Chaganti, R., Pollard, J. W., Kolodner, R. D., and Kucherlapati, R. (1996) Cell 85, 1125-1134[CrossRef][Medline] [Order article via Infotrieve]
  50. Philipova, R., Kisielewska, J., Lu, P., Larman, M., Huang, J.-Y., and Whitaker, M. J. (2005) Development 132, 579-589[Abstract/Free Full Text]
  51. Alessi, D. R., Smythe, C., and Keyse, S. M. (1993) Oncogene 8, 2015-2020[Medline] [Order article via Infotrieve]
  52. Sun, H., Charles, C. H., Lau, L. F., and Tonks, N. K. (1993) Cell 75, 487-493[CrossRef][Medline] [Order article via Infotrieve]
  53. Lewis, T., Groom, L. A., Sneddon, A. A., Smythe, C., and Keyse, S. M. (1995) J. Cell Sci. 108, 2885-2896[Abstract]
  54. Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Vandyk, D. E., Pitts, W. J., Earl, R. A., Hobbs, F., Copeland, R. A., Magolda, R. L., Scherle, P. A., and Trzaskos, J. M. (1998) J. Biol. Chem. 273, 18623-18632[Abstract/Free Full Text]
  55. DeSilva, D. R., Jones, E. A., Favata, M. F., Jaffe, B. D., Magolda, R. L., Trzaskos, J. M., and Scherle, P. A. (1998) J. Immunol. 160, 4175-4181[Abstract/Free Full Text]
  56. Meijer, L., Borgne, A., Mulner, O., Chong, J. P. J., Blow, J. J., Inagaki, N., Inagaki, M., Delcors, J.-G., and Moulinoux, J.-P. (1997) Eur. J. Biochem. 243, 527-536[Medline] [Order article via Infotrieve]
  57. Alessi, F., Quarta, S., Sario, M., Riva, F., Rossi, L., Stivala, L. A., Scovassi, A. I., Meijer, L., and Prosperi, E. (1998) Exp. Cell Res. 245, 8-18[CrossRef][Medline] [Order article via Infotrieve]
  58. Schatten, G., Schatten, H., Bestor, T. H., and Balczon, R. (1982) J. Cell Biol. 94, 455-465[Abstract/Free Full Text]
  59. Xiong, W., and Ferrell James, E. (2003) Nature 426, 460-465[CrossRef][Medline] [Order article via Infotrieve]
  60. Downes, C. S., Clarke, D. J., Mullinger, A. M., Gimernez-Abian, J. F., Creighton, A. M., and Johnson, R. T. (1994) Nature 372, 467-470[CrossRef][Medline] [Order article via Infotrieve]
  61. Koshland, D., and Strunnikov, A. (1996) Annu. Rev. Cell Dev. Biol. 12, 305-333[CrossRef][Medline] [Order article via Infotrieve]
  62. Moudrianakis, E. N., and Arents, G. (1993) Cold Spring Harbor Symp. Quant. Biol. 58, 273-279[Medline] [Order article via Infotrieve]
  63. Bradbury, E. M. (1992) BioEssays 14, 9-16[CrossRef][Medline] [Order article via Infotrieve]
  64. Guo, X. W., Th'ng, J. P., Swank, R. A., Anderson, H. J., Tudan, C., Bradbury, E. M., and Roberge, M. (1995) EMBO J. 14, 976-985[Medline] [Order article via Infotrieve]
  65. Sassone-Corsi, P., Mizzen, C. A., Cheung, P., Crosio, C., Monaco, L., Jacquot, S., Hanauer, A., and Allis, C. D. (1999) Science 285, 886-891[Abstract/Free Full Text]
  66. Cheung, P., Tanner, K. G., Cheung, W. L., Sassone-Corsi, P., Denu, J. M., and Allis, C. D. (2000) Mol. Cell. Biol. 5, 905-915
  67. Shapiro, P. S., Whalen, A. M., Tolwinski, N. S., Wilsbacher, J., Froelich-Ammon, S. J., Garcia, M., Osheroff, N., and Ahn, N. G. (1999) Mol. Biol. Cell 19, 3551-3560
  68. Geneviere-Garrigues, A.-M., Barakat, A., Doree, M., Moreau, J.-L., and Picard, A. (1995) J. Cell Sci. 108, 2693-2703[Abstract]
  69. Nishioka, D., Balczon, R., and Schatten, G. (1984) Cell Biol. Int. Rep. 8, 337-346[CrossRef][Medline] [Order article via Infotrieve]
  70. Olsen, M. K., Reszka, A. A., and Abraham, I. (1998) J. Cell Biol. 176, 525-536
  71. Gotoh, Y., Nishida, E., Matsuda, S., Shiina, N., Kosako, H., Shiokawa, K., Akiyama, T., Ohta, K., and Sakai, H. (1991) Nature 349, 251-254[CrossRef][Medline] [Order article via Infotrieve]
  72. Shiina, N., Moriguchi, T., Ohta, K., Gotoh, Y., and Nishida, E. (1992) EMBO J. 11, 3977-3984[Medline] [Order article via Infotrieve]
  73. Hoshi, M., Ohta, K., Gotoh, Y., Mori, A., Murofushi, H., Sakai, H., and Nishida, E. (1992) Eur. J. Biochem. 203, 43-52[Medline] [Order article via Infotrieve]
  74. Drechsel, D. N., Hyman, A. A., Cobb, M. H., and Kirschner, M. W. (1992) Mol. Biol. Cell 3, 1141-1154[Abstract]
  75. Marklund, U., Brattsand, G., Osterman, O., Ohlsson, P. I., and Gullberg, M. (1993) J. Biol. Chem. 268, 25671-25680[Abstract/Free Full Text]
  76. Brattsand, G., Marklund, U., Nylander, K., Roos, G., and Gullberg, M. (1994) Eur. J. Biochem. 220, 359-368[Medline] [Order article via Infotrieve]
  77. Larsson, N., Melander, H., Marklund, U., Osterman, O., and Gullberg, M., (1995) J. Biol. Chem. 270, 14174-14183
  78. Belmont, L. D., and Mitchison, T. J. (1996) 84: 623-631
  79. Kumano, M., Carroll, D. J., Denu, J. M., and Foltz, K. R. (2001) Dev. Biol. 236, 244-257